What Comes Next Could Be a Once-in-a-Lifetime Opportunity

A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.

Click here now to watch the full briefing and discover the steps to take today.

LABP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 1.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Landos Biopharma Insider Trading History Chart

Landos Biopharma Share Price & Price History

^$22.93

▲ +0.13 (0.57%)

As of 05/23/2024 09:56 PM ET

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

Get Your Free Gold Guide

Landos Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/23/2022	Rtw Investments, Lp	Major Shareholder	Sell	30,000	$6.90	$207,000.00	397,572
12/20/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	3,319	$47.50	$157,652.50
12/17/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	3,600	$48.40	$174,240.00
12/15/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	4,300	$50.20	$215,860.00
12/13/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	4,000	$53.70	$214,800.00
12/10/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	4,000	$57.70	$230,800.00
12/8/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	2,553	$66.50	$169,774.50
12/6/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	3,600	$61.70	$222,120.00
12/3/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	3,600	$61.50	$221,400.00
12/1/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	3,223	$70.10	$225,932.30
11/29/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	1,543	$75.80	$116,959.40

Central Bank Abandons USD

From Desko Digital | Ad

You know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our exploding national debt, VOTE FOR GOLD!

Get Your FREE Gold Investor Kit NOW!

SEC Filings (Institutional Ownership Changes) for Landos Biopharma (NASDAQ:LABP)

49.06% of Landos Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Landos Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/20/2024	Virtu Financial LLC	14,537	$0.31M	0.0%	N/A	0.464%
5/16/2024	Black Maple Capital Management LP	10,405	$0.22M	0.1%	N/A	0.332%
4/17/2024	Deltec Asset Management LLC	50,000	$1.07M	0.2%	N/A	1.603%
8/24/2023	Perceptive Advisors LLC	1,486,991	$6.26M	0.2%	-90.0%	47.660%
11/14/2022	RTW Investments LP	3,975,722	$2.58M	0.1%	-7.0%	9.876%
11/1/2022	OUP Management Co. LLC	1,237,667	$0.80M	1.3%	-23.3%	3.074%
10/31/2022	Green Square Capital Advisors LLC	84,500	$55K	0.0%	N/A	0.210%
7/19/2022	OUP Management Co. LLC	1,612,764	$1.17M	1.6%	-11.7%	4.006%
3/3/2022	Walleye Capital LLC	105,208	$0.51M	0.0%	N/A	0.262%
2/10/2022	Acadian Asset Management LLC	8,274	$39K	0.0%	N/A	0.021%
2/3/2022	OUP Management Co. LLC	1,827,478	$8.77M	4.0%	N/A	4.555%
11/12/2021	Geode Capital Management LLC	112,933	$1.65M	0.0%	-11.4%	0.282%
11/12/2021	Botty Investors LLC	128,750	$1.88M	0.6%	+4.9%	0.321%
11/9/2021	BlackRock Inc.	233,616	$3.41M	0.0%	-20.6%	0.582%
11/4/2021	Deutsche Bank AG	2,693	$39K	0.0%	-30.0%	0.007%
11/2/2021	Cambridge Investment Research Advisors Inc.	18,831	$0.28M	0.0%	N/A	0.047%
11/2/2021	New York State Common Retirement Fund	2,756	$40K	0.0%	-62.5%	0.007%
11/2/2021	Allworth Financial LP	5,286	$77K	0.0%	N/A	0.013%
10/22/2021	Strs Ohio	11,400	$0.17M	0.0%	+660.0%	0.028%
8/17/2021	Logos Global Management LP	899,106	$10.39M	0.9%	+22.5%	2.241%
8/16/2021	Tudor Investment Corp Et Al	17,793	$0.21M	0.0%	-71.3%	0.044%
8/16/2021	State Street Corp	92,367	$1.07M	0.0%	+88.1%	0.230%
8/13/2021	Botty Investors LLC	122,781	$1.42M	0.5%	+26.0%	0.306%
8/13/2021	Geode Capital Management LLC	127,518	$1.47M	0.0%	+15.3%	0.318%
8/13/2021	Vanguard Group Inc.	305,185	$3.52M	0.0%	+61.9%	0.761%
8/11/2021	Bank of New York Mellon Corp	14,029	$0.16M	0.0%	+37.8%	0.035%
8/11/2021	BlackRock Inc.	294,043	$3.40M	0.0%	+14.7%	0.733%
5/27/2021	Davidson Kempner Capital Management LP	50,000	$0.48M	0.0%	N/A	0.125%
5/19/2021	Logos Global Management LP	734,000	$7.07M	0.7%	N/A	1.830%
5/19/2021	Squarepoint Ops LLC	15,361	$0.15M	0.0%	N/A	0.038%
5/18/2021	Zimmer Partners LP	90,100	$0.87M	0.0%	N/A	0.225%
5/18/2021	Tudor Investment Corp Et Al	61,899	$0.60M	0.0%	N/A	0.154%
5/18/2021	Orbimed Advisors LLC	681,000	$6.56M	0.1%	N/A	1.697%
5/18/2021	Davidson Kempner Capital Management LP	50,000	$0.48M	0.0%	N/A	0.125%
5/18/2021	Old Well Partners LLC	18,316	$0.18M	0.1%	N/A	0.046%
5/18/2021	California State Teachers Retirement System	9,518	$92K	0.0%	N/A	0.024%
5/17/2021	Deerfield Management Company L.P. Series C	450,000	$4.33M	0.1%	N/A	1.122%
5/17/2021	Perceptive Advisors LLC	17,960,839	$159.69M	2.0%	N/A	44.770%
5/17/2021	Woodline Partners LP	213,335	$2.05M	0.0%	N/A	0.532%
5/17/2021	Caas Capital Management LP	40,000	$0.39M	0.0%	N/A	0.100%
5/17/2021	Nuveen Asset Management LLC	10,219	$98K	0.0%	N/A	0.025%
5/17/2021	Sphera Funds Management LTD.	70,000	$0.67M	0.1%	N/A	0.174%
5/14/2021	Laurion Capital Management LP	10,000	$96K	0.0%	N/A	0.025%
5/14/2021	RTW Investments LP	4,275,722	$38.33M	0.6%	N/A	10.658%
5/14/2021	Monashee Investment Management LLC	91,309	$0.88M	0.1%	N/A	0.228%
5/13/2021	Bank of New York Mellon Corp	10,182	$98K	0.0%	N/A	0.025%
5/13/2021	Botty Investors LLC	97,477	$0.94M	0.3%	N/A	0.243%
5/12/2021	Northern Trust Corp	74,359	$0.72M	0.0%	N/A	0.185%
5/12/2021	Geode Capital Management LLC	110,559	$1.06M	0.0%	N/A	0.276%
5/12/2021	Ensign Peak Advisors Inc	125,000	$1.20M	0.0%	N/A	0.312%
5/12/2021	JPMorgan Chase & Co.	375,021	$3.61M	0.0%	N/A	0.935%
5/11/2021	Teacher Retirement System of Texas	10,000	$96K	0.0%	N/A	0.025%
5/11/2021	New York State Common Retirement Fund	7,300	$70K	0.0%	N/A	0.018%
5/7/2021	BlackRock Inc.	256,290	$2.47M	0.0%	N/A	0.639%
5/7/2021	American International Group Inc.	3,677	$35K	0.0%	N/A	0.009%

Data available starting January 2016

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate is NX-13, an oral gut-selective Nucleotide Oligomerization Domain (NLRX1), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines that is in Phase 2 clinical trial to treat ulcerative colitis (UC) and completed Phase 1 to treat Crohn's disease (CD). The company's preclinical candidates in development include LABP-73, an oral and small molecule NLRX1 pathway agonist for the treatment of asthma and eosinophilic disorders; LABP-66 is an oral and small molecule NLRX1 pathway agonist for the treatment of multiple sclerosis and neurodegenerative disorders; and LABP-69, an oral PLXDC2 agonist for the treatment of rheumatoid arthritis, UC, and CD. The company has a license and collaboration agreement with LianBio Respiratory Limited to develop, manufacture, and commercialize omilancor and NX-13. Landos Biopharma, Inc. was incorporated in 2017 and is headquartered in Blacksburg, Virginia.

Today's Range

Now: $22.93

$22.75

$22.94

50 Day Range

MA: $22.54

$21.51

$22.93

52 Week Range

Now: $22.93

$2.50

$22.94

Volume

50,800 shs

Average Volume

19,700 shs

Market Capitalization

$71.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.14

What Comes Next Could Be a Once-in-a-Lifetime Opportunity

From InvestorPlace | Ad

Click here now to watch the full briefing and discover the steps to take today.